Table 1.
MAP4343-Treated Group | Fluoxetine-Treated Group | |
---|---|---|
Body weight loss | - | - |
LMA reduction | + | n.d. |
Cortisol increase | +/- | - |
Noradrenaline increase | + | + |
CBT elevation | + | + |
Sleep disturbances | + | +/- |
Abbreviations: CBT, core body temperature; LMA, locomotor activity; n.d., not determined (accidental troubles in the animal room have precluded obtaining of quantitative results); + refers to significant efficacy preventing physiological changes; +/- refers to variable efficacy preventing physiological changes; - refers to an absence of efficacy preventing physiological changes;